CWP232291

· JW Pharmaceutical

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CWP232291, covering 2016-03-08 to 2025-12-26. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients [Phase 1, Phase 2]